Paradigm Biopharmaceuticals Secures Ethics Committee Approval for Phase Three Knee Osteoarthritis Clinical Trial

MT NewswiresFeb 23 21:02 ET

Paradigm Biopharmaceuticals Ltd. (PBIGF) Receives a Buy From Bell Potter

TipRanksFeb 2 19:06 ET · Ratings

Paradigm Biopharmaceuticals Selects Clinical Research Organization for Osteoarthritis Trial; Shares Up 4%

MT NewswiresJan 30 20:33 ET

Paradigm Biopharmaceuticals Ltd: Paradigm Receives $6.3m R&D Tax Refund

ASXJan 23 16:59 ET · Announcements

Why These Small Cap ASX Shares Could Deliver Very Big Returns in 2025

The Motley FoolJan 7 22:17 ET

6 ASX All Ords Shares Lifted to 'Strong Buy' Consensus Ratings for the New Year

The Motley FoolJan 1 18:56 ET